Slower Gastric Emptying : The medication slows the rate at which food leaves the stomach, leading to prolonged feelings of fullness
Early clinical trials have shown large, dose-related weight loss in people with obesity
Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease, and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
It documents how Willow separates platform control from clinician authority and where variability enters the process
The choice to use retatrutide should be informed by accurate information, personal medical circumstances, financial considerations, and individual risk tolerance
Step 3: Apply and Complete Screening When you find a trial that you think is right for you, youll need to reach out to the sponsor listed on the trial